Home / Letter From The Editor / Nov. 9, 2019

Nov. 9, 2019

Nov 9, 2019

Medication persistence gets a lot of attention these days, as we all have seen patients discontinue or miss doses of chronic medications. Sometimes it is the pill burden, and for others it is the multiple copays for all the medications they get from the pharmacy. If you add the burden of different refills due on different days, you can understand why patients stop taking some or all of their medications.

Many manufacturers make combination products with two medications for diabetes, but just recently Astra-Zeneca took a bold step and added a third drug to their combination SGLT-2 Inhibitor, DPP4-Inhibitor. The new combination, called Qternmet XR, adds metformin in a single pill.

Nice thing about this triple therapy is that the price of all three meds in a single tablet is about the same as either brand alone. This means cash patients will have less out of pocket, and insured patients will have one copay instead of three.



We can make a difference!


Dave Joffe